Why is Ind-Swift Labs. falling/rising?

As of 11-Sep, Ind-Swift Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 109.35, which represents a decrease of Rs 2.64 or 2.36%. Today's price summary indicates that the stock has underperformed its sector by 2.83% and has fallen after four consecutive days of gains, touching an intraday low of Rs 106. The stock is trading above its moving averages, but the weighted average price suggests that more volume was traded closer to the low price. Over the past week, the stock has shown a return of +8.26%, but it has significantly underperformed over the last year with a return of -24.77%. The company's weak long-term fundamentals, including a -196.09% CAGR growth in operating profits over the last five years and negative results for the last four consecutive quarters, contribute to the stock's downward movement.
Broader market context shows that while the Sensex has gained 1.03% over the past week, Ind-Swift Laboratories Ltd's performance has been notably weaker, indicating a lack of investor confidence. The stock's negative EBITDA and high debt-to-EBITDA ratio further exacerbate its risk profile, making it less attractive compared to the broader market. Despite a rise in investor participation, the overall sentiment remains cautious due to the company's declining profitability and inability to service its debt effectively. This combination of poor financial performance and market conditions has led to the stock's current decline.